Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 23459716)

1.

Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomy.

Brücher B, Stojadinovic A, Bilchik A, Protic M, Daumer M, Nissan A, Itzhak A.

J Cancer. 2013;4(3):262-9. doi: 10.7150/jca.5831. Epub 2013 Mar 15.

2.
3.

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.

Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.

Eur J Surg Oncol. 2013 Nov;39(11):1207-13. doi: 10.1016/j.ejso.2013.08.017. Epub 2013 Sep 2.

PMID:
24007834
4.
5.

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.

Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.

In Vivo. 2010 Jan-Feb;24(1):79-84.

PMID:
20133981
6.

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP.

Ann Surg. 2006 Feb;243(2):212-22. Review.

7.

Randomized clinical trials for colorectal cancer peritoneal surface malignancy.

Avital I, Brücher BL, Nissan A, Stojadinovic A.

Surg Oncol Clin N Am. 2012 Oct;21(4):665-88. doi: 10.1016/j.soc.2012.07.004. Review.

PMID:
23021723
9.
10.

Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Weber T, Roitman M, Link KH.

Clin Colorectal Cancer. 2012 Sep;11(3):167-76. doi: 10.1016/j.clcc.2012.01.001. Epub 2012 Mar 6. Review.

PMID:
22397952
11.

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.

J Clin Oncol. 2003 Oct 15;21(20):3737-43.

PMID:
14551293
12.

[Surgical Management of Peritoneal Surface Malignancy with Respect to Tumour Type, Tumour Stage and Individual Tumour Biology.]

Beckert S, Struller F, Grischke EM, Glatzle J, Zieker D, Königsrainer A, Königsrainer I.

Zentralbl Chir. 2013 Nov 15. [Epub ahead of print] German.

PMID:
24241953
13.

Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.

de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA.

Cancer Treat Rev. 2013 Jun;39(4):321-7. doi: 10.1016/j.ctrv.2012.11.003. Epub 2012 Dec 12. Review.

PMID:
23244778
14.

Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer.

Ströhlein MA, Bulian DR, Heiss MM.

Expert Rev Anticancer Ther. 2011 Oct;11(10):1505-8. doi: 10.1586/era.11.147.

PMID:
21999124
15.

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.

Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.

Ann Surg Oncol. 2012 Jul;19(7):2186-94. doi: 10.1245/s10434-012-2264-z. Epub 2012 Mar 7.

PMID:
22395983
16.

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.

Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.

PMID:
18521686
17.

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.

Glockzin G, Rochon J, Arnold D, Lang SA, Klebl F, Zeman F, Koller M, Schlitt HJ, Piso P.

BMC Cancer. 2013 Feb 7;13:67. doi: 10.1186/1471-2407-13-67.

18.

A critical look at local-regional management of peritoneal metastasis.

Chan CH, Cusack JC, Ryan DP.

Hematol Oncol Clin North Am. 2015 Feb;29(1):153-8. doi: 10.1016/j.hoc.2014.09.006.

PMID:
25475577
19.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y.

Ann Surg Oncol. 2011 Jun;18(6):1575-81. doi: 10.1245/s10434-011-1631-5. Epub 2011 Mar 23.

20.

Current management of peritoneal carcinomatosis from colorectal cancer.

Ceelen WP.

Minerva Chir. 2013 Feb;68(1):77-86. Review.

PMID:
23584267
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk